Anyone interested in company in cancer immunotherapy?
Dear Yinglan
Another global impact project which we are doing.
This is in the space of cancer immunotherapy i.e. using own immune systemto fight cancer cells, with practically zero side effects. Dandreon Corporation is in the same space as us, but focussing only on prostrate cancer while we can target 8 of the top 10 cancer types in the world. Nasdaq-listed Dandreon Corporation's current market cap is above US$2 billion.
NCC is likely to be the lead co-ordinator for the mult-centre US FDA Fast Track trial if we succeed to raise funding out of Spore. This is a Denmark co. which I have a significant stake. We are prepared to relocat to Spore: lock, stock and barrel. But unfortunately we could not even interest Bio One to talk to us. NCC is highly supportive but has no investment fund. NCC will take a small equity stake, in return for payment in kind as one of the key centres for the FDA trial.
Pl see attachment for synopsis. Much more scientific info available if interested.
francis
